Patents by Inventor Yael Friedmann

Yael Friedmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8048993
    Abstract: According to the present invention there is provided an antibody that specifically binds an epitope of a heparanase protein, the heparanase protein including an amino acid sequence as set forth in SEQ ID NO:2, provided that phenylalanine replaces tyrosine at position 246. The present invention also provides an antibody elicited by an epitope of a heparanase protein, the heparanase protein including an amino acid sequence as set forth in SEQ ID NO:2, provided that phenylalanine replaces tyrosine at position 246.
    Type: Grant
    Filed: January 4, 2008
    Date of Patent: November 1, 2011
    Assignees: InSight Biopharmaceuticals Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Patent number: 7790376
    Abstract: Heparanase specific molecular probes which can be used for detection of the presence, absence or level of heparanase expression and methods of utilizing same are provided.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: September 7, 2010
    Assignees: InSight Biopharmaceuticals Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Publication number: 20090099341
    Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
    Type: Application
    Filed: January 4, 2008
    Publication date: April 16, 2009
    Applicants: InSight Biopharmaceuticals Ltd., Hadasit Medical Research Services
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Patent number: 7339038
    Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: March 4, 2008
    Assignees: InSight Biopharmaceuticals Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Patent number: 6986996
    Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: January 17, 2006
    Assignees: Insight Biopharmaceuticals Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Patent number: 6946131
    Abstract: A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: September 20, 2005
    Assignees: InSight Biopharmacenticals Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Tuvia Peretz, Daphna Miron, Yinon Shlomi, Iris Pecker, Maty Ayal-Hershkovitz, Israel Vlodavsky, Yael Friedmann
  • Publication number: 20040229834
    Abstract: Heparanase specific molecular probes which can be used for detection of the presence, absence or level of heparanase expression and methods of utilizing same are provided.
    Type: Application
    Filed: May 24, 2004
    Publication date: November 18, 2004
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Publication number: 20040213789
    Abstract: Specific anti-heparanase antibodies which bind specifically to heparanase having sequence homology to human heparanase, which can be used to treat and diagnose conditions associated with heparanase catalytic activity, for purification of heparanase, and for drug development in heparanase associated conditions are disclosed.
    Type: Application
    Filed: August 22, 2003
    Publication date: October 28, 2004
    Inventors: Oron Yacoby-Zeevi, Tuvia Peretz, Daphna Miron, Yinon Shlomi, Iris Pecker, Maty Ayal-Hershkovitz, Elena Feinstein, Joel M. Van Gelder, Israel Vlodavsky, Yael Friedmann
  • Publication number: 20040170631
    Abstract: Specific anti-heparanase antibodies which bind specifically to heparanase having sequence homology to human heparanase, which can be used to treat and diagnose conditions associated with heparanase catalytic activity, for purification of heparanase, and for drug development in heparanase associated conditions are disclosed.
    Type: Application
    Filed: November 28, 2003
    Publication date: September 2, 2004
    Inventors: Oron Yacoby-Zeevi, Tuvia Peretz, Daphna Miron, Yinon Shlomi, Iris Pecker, Maty Ayal-Hershkovitz, Elena Feinstein, Joel M. Van Gelder, Israel Vlodavsky, Yael Friedmann
  • Publication number: 20040146925
    Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
    Type: Application
    Filed: February 26, 2004
    Publication date: July 29, 2004
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Publication number: 20040063135
    Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and the use of a heparanase specific molecular probe as a therapeutic agent.
    Type: Application
    Filed: October 2, 2003
    Publication date: April 1, 2004
    Applicants: Insight Strategy & Marketing Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Iris Pecker, Israel Vlodavsky, Yael Friedmann, Tuvia Peretz
  • Publication number: 20030181687
    Abstract: A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.
    Type: Application
    Filed: February 19, 2003
    Publication date: September 25, 2003
    Inventors: Tuvia Peretz, Daphna Miron, Yinon Shlomi, Iris Pecker, Maty Ayal-Hershkovitz, Israel Vlodavsky, Yael Friedmann
  • Patent number: 6562950
    Abstract: A monoclonal antibody elicited by a heparanase protein or an immunogenical portion thereof, the monoclonal antibody specifically inhibits heparanase activity.
    Type: Grant
    Filed: November 4, 1998
    Date of Patent: May 13, 2003
    Assignees: Insight Strategy & Marketing Ltd., Hadasit Medical Research Services and Development Ltd.
    Inventors: Tuvia Peretz, Daphna Miron, Yinon Shlomi, Iris Pecker, Maty Ayal-Hershkovitz, Israel Vlodavsky, Yael Friedmann
  • Publication number: 20020068061
    Abstract: A monoclonal antibody elicited by a heparanase protein or an immunogenical portion thereof, the monoclonal antibody specifically inhibits heparanase activity.
    Type: Application
    Filed: November 4, 1998
    Publication date: June 6, 2002
    Inventors: TUVIA PERETZ, DAPHNA MIRON, YINON SHLOMI, IRIS PECKER, MATY AYAL-HERSHKOVITZ, ISREAL VLODAVSKY, YAEL FRIEDMANN